MRD conversion during oral azacitidine maintenance correlates with outcomes in predominantly favorable-risk AML. - Hurvitz N; Amitai I; Yurkovski IL; Tvito A; Ofran Y; Porges T; Wolach O; Sherban A; Even-Zohar NG; Vainstein V; Haran A; Aumann S; et al. (Annals of hematology, 2026)